GILD

Gilead Sciences Inc

Jun 12 • 04:00PM ET

125.59

-0.28 -0.22 %

Healthcare • Drug Manufacturers - General • USA • Large • NASD

Peers: AMGN REGN VRTX BIIB ABBV BMY LLY MRK ALNY ARGX

| Held by: VTI VOO QQQ IVV SPY VTV XLV VIG QQQM VYM

Scroll to Statements

Index	NDX, S&P 500	P/E	17.09	EPS (ttm)	7.35	Insider Own	0.14%	Shs Outstand	1.24B	Perf Week	-2.76%
Market Cap	155.93B	Forward P/E	12.94	EPS next Y	9.70	Insider Trans	-18.22%	Shs Float	1.24B	Perf Month	-5.61%
Enterprise Value	168.20B	PEG	1.41	EPS next Q	-6.94	Inst Own	88.78%	Short Float	2.07%	Perf Quarter	-13.38%
Income	9.22B	P/S	5.23	EPS this Y	-105.10%	Inst Trans	-1.49%	Short Ratio	3.88	Perf Half Y	3.50%
Sales	29.79B	P/B	6.63	EPS next Y	2434.12%	ROA	16.35%	Short Interest	25.73M	Perf YTD	2.32%
Book/sh	18.93	P/C	15.88	EPS next 5Y	9.20%	ROE	43.19%	52W High	157.29 -20.15%	Perf Year	12.08%
Cash/sh	7.91	P/FCF	15.24	EPS past 3/5Y	23.06% 133.64%	ROIC	20.77%	52W Low	104.46 20.23%	Perf 3Y	61.30%
Dividend Est.	3.24 (2.58%)	EV/EBITDA	11.39	Sales past 3/5Y	2.83% 3.63%	Gross Margin	79.41%	Volatility	3.49% 2.62%	Perf 5Y	82.62%
Dividend TTM	3.19 (2.54%)	EV/Sales	5.65	EPS Y/Y TTM	55.01%	Oper. Margin	40.41%	ATR (14)	3.57	Perf 10Y	48.72%
Dividend Ex-Date	Jun 15, 2026	Quick Ratio	1.77	Sales Y/Y TTM	3.83%	Profit Margin	30.94%	RSI (14)	40.40	Recom	1.53
Dividend Gr. 3/5Y	2.67% 3.04%	Current Ratio	1.97	EPS Q/Q	54.29%	SMA20	-3.24%	Beta	0.35	Target Price	160.54
Payout	46.60%	Debt/Eq	0.94	Sales Q/Q	5.09%	SMA50	-5.55%	Rel Volume	0.78	Prev Close	125.87
Employees	17000	LT Debt/Eq	0.89	Earnings	May 07 AMC	SMA200	-2.76%	Avg Volume	6.62M	Price	125.59
IPO	Jan 22, 1992	Option/Short	Yes / Yes	EPS/Sales Surpr.	6.31% 0.67%	Trades		Volume	5,199,593	Change	-0.22%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)